Результаты поиска

A nationwide survey of knowledge of and compliance with cancer pain management guidelines by korean physicians.

PurposeAlthough cancer pain is prevalent, under-treatment still remains a problem. Knowledge of and compliance with guidelines for management of cancer pain were analyzed for exploration of physician-related barriers to cancer pain management. In addition, physicians' knowledge and its correlation with cancer pain control were audited.Materials and methodsFrom July 8 to December 2, 2010, a nationwide survey of house staff enquired about their knowledge of cancer pain control guidelines, and the medical records of patients under their care were analyzed.ResultsIn total, 180 physicians participa

Совпадение в полном тексте источника
… Indeed, most medical oncologists would readily perform active diagnostic imaging and/or anticancer treatment before pain control. However, many patients do not have to endure pain during evaluation and/or treatment. … In particular, knowledge and prescribing preferences were based primarily on medical oncologists. The findings might have been different had the survey included physicians of other specialties. …

Too short or unnecessarily long: walking the fine line.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… The answers to these questions may reside not in staying within a close distance and following up at the CAR T-cell therapy center frequently but in engaging oncologists beyond the specific centers in the aftercare of CAR T-cell therapy. … The onus is now upon the CAR T-cell treatment centers and manufacturing companies perhaps in partnership with the leading academic societies to foster collaboration with oncologists over the map of the United States and allow a safe transition of care after early follow-up at the CAR T-cell treatment …

Does anxiety influence the use of complementary or alternative medicine among cancer patients?

PurposeThe aim of this study was to investigate the extent to which patients' anxiety due to their cancerous disease has an influence on the use of complementary and alternative medicine (CAM) methods.Methods230 patients completed an anonymous voluntary questionnaire that was sent to outpatient oncological facilities participating in the survey. This questionnaire included standardised tests such as the Allgemeine Selbstwirksamkeit Kurzskala (ASKU, self-efficacy short scale) and the State-Trait-Anxiety-Inventory (STAI) as well as socio-demographic information and a section on CAM use. Statisti

Совпадение в полном тексте источника
… Beyond that, oncologists should offer psycho-oncological support to reduce depression and anxiety symptoms in patients (Civilotti et al. 2023 ; Goerling et al. 2011 ). … For this reason, oncologists should know about the intake of CAM substances in addition to cancer therapy and prevent vulnerable cancer patients from risks of CAM usage. …

Беспокойство и депрессия у пациентов, у которых недавно диагностировали лимфому и миэлому.

Несмотря на то, что лимфома и миэлома создают физическое и психологическое бремя, данные о тревожности и симптомах депрессии у затронутых пациентов ограничены. Мы провели обследование в июле 2021 и сентябрь 2022 для характеристики тревоги и депрессии в группе взрослых пациентов, внутри 6 месяцев лимфомы или миэломы диагноза. Клинически значимая тревога и симптомы депрессии были определены как десятки ≥8 о соответствующих подмасштабах шкалы больничных тревог и депрессии. Мы провели оценку социально-демографических факторов, связанных с симптомами тревоги/депрессии, и проанализировали взаимосвяз

Совпадение в полном тексте источника
… Between July 2021 and September 2022, eligible patients were identified from weekly clinic schedules and permission to approach was requested from each patient’s primary oncologist. … Measurement selection Our multidisciplinary research team consisting of hematologic oncologists, a nurse-scientist, clinical psychologists, and clinical psychology doctoral students compiled a survey consisting of previously published and validated instruments 20 , 21 , 22 , 23 , 24 as well as new questions …

Safety and toxicity of Iopofosine I 131 (CLR 131) with external beam radiation therapy in recurrent or metastatic head and neck cancer: results of a phase 1 single-centre, open-label, single-arm, dose escalation and dose expansion study.

BACKGROUND: Re-irradiation of recurrent head and neck cancer (HNC) is often limited by tumour adherence to critical structures and/or radiation tolerance of critical normal tissues. Iopofosine I 131 (CLR 131) is a targeted small molecular phospholipid ether (PLE) drug conjugate that delivers iodine-131 selectively to tumour cells. We conducted a phase 1, single-centre, open-label study to determine whether CLR 131 given with reduced dose of external beam radiation therapy (EBRT) would be tolerable and feasible. METHODS: All participants received previous curative intent treatment with radioth

Practice variations in indication, timing and outcome of Multiple Myeloma patients undergoing surgery for vertebral lesions - results from the European M2Spine study group.

PURPOSE: Painful vertebral lesions are pathognomonic in Multiple Myeloma (MM). While non-surgical management is generally preferred, some patients ultimately require surgical intervention. Here we describe the largest European cohort of MM patients with vertebral lesions to examine the practice variations of spine surgery in means of indication, timing and outcome. METHODS: This study included patients with MM vertebral lesions enrolled in the European M2Spine Registry (DRKS00033326) at seven European academic spine centers between 2005 and 2023. Retrospective analysis evaluated epidemiologic

Совпадение в полном тексте источника
… Second, despite the interdisciplinary care provided, involving hemato-oncologists, radio-oncologists, and spine surgeons, a certain proportion of patients received hematological therapies and/or radiotherapy at institutions outside the study centers. … Oncologist 21:95–101. 10.1634/theoncologist.2015-0266 29. Laufer I, Iorgulescu JB, Chapman T et al (2013) Local disease control for spinal metastases following separation surgery and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients. …

Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy.

Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common and disabling dose-limiting toxicities of chemotherapy. We report here the results of two separate non-interventional studies (49 patients), which evaluated blood neurofilament light chain (NfL) as a biomarker of CIPN in breast cancer patients treated with paclitaxel. All patients underwent a standard treatment protocol that was established independently of the present studies. NfL was measured in serum using an ultrasensitive single-molecule array and compared with the self-administered European Organization for Resea

Corneal Nerve Changes Observed by In Vivo Confocal Microscopy in Patients Receiving Oxaliplatin for Colorectal Cancer: The COCO Study.

An objective method of early identification of people at risk of chemotherapy-induced peripheral neuropathy is needed to minimize long-term toxicity and maximize dose intensity. The aims of the study were to observe corneal nerve microstructure and corneal sensitivity changes and peripheral neuropathy in patients receiving oxaliplatin, and to determine its association with corneal parameters at different stages of treatment and assess utility as non-invasive markers to detect and monitor peripheral neuropathy. Twenty-three patients scheduled to receive oxaliplatin chemotherapy with intravenous

Совпадение в полном тексте источника
… Whereas oncologists decrease the dose delivered or terminate oxaliplatin therapy in response to the development of peripheral neuropathy, the dose adjustment often occurs too late to prevent chronic permanent peripheral neuropathy [ 16 ]. … Overall, patients expressed anxiety at the initial recruitment approach at the Oncology New Patient clinic, and although most patients were already aware of their diagnosis of cancer, this was their first meeting with an oncologist. …

A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncology.

BACKGROUND: Clinicians have limited time during patient encounters which can result in patients' concerns not being addressed. This study's objective was to test whether an electronic patient-reported outcome quality of life tool (PROQOL) in which patients identify their primary concern during clinic visits improves cancer patient quality of life (QOL). PATIENTS AND METHODS: This single center non-blinded prospective clinical trial randomized patients (2:1) to PROQOL versus usual care (UC). Two patient cohorts were enrolled: those with hematologic malignancies (multiple myeloma [MM] or light

Совпадение в полном тексте источника
… Prognosis, treatment benefit and goals of care: what do oncologists discuss with patients who have incurable cancer? Clin. Oncol. 28 3 2016 Mar 209 214 10.1016/j.clon.2015.11.011 26698027 28 Scotté F. Bossi P. Carola E. Cudennec T. Dielenseger P. Gomes F. … Discussing prognosis and treatment goals with patients with advanced cancer: a qualitative analysis of oncologists' language Heal Expect an Int J public Particip Heal care Heal policy 20 5 2017 Oct 1073 1080 10.1111/hex.12549 PMC5600249 28261901 30 Gilligan T. Coyle N. Frankel R.M. Berry D.L. …

Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task.

Central diabetes insipidus (CDI) is a rare endocrine disease deriving from an insufficient production or secretion of anti-diuretic hormone. Recently, CDI has been reported as a rare side effect triggered by immune checkpoint inhibitors (ICI) in cancer patients. Despite its current rarity, CDI triggered by ICI is expected to affect an increasing number of patients because of the expanding use of these effective drugs in a growing number of solid and hematologic malignancies. An appropriate assessment of the severity of adverse events induced by anticancer agents is crucial in their management,

Совпадение в полном тексте источника
… As in other rare irAEs triggered by ICI ( 65 ), with the growing clinical use of these agents, a better knowledge of the CDI syndrome induced by ICI may help oncologists early suspect its onset and early activation endocrinologist consultation. … Oncologist ( 2020 ) 25 : 6 – 14 . doi: 10.1634/theoncologist.2019-0083 31694890 PMC6964128 66 Del Re M Cinieri S Michelucci A Salvadori S Loupakis F Schirripa M . …

The psychosocial cost burden of cancer: A systematic literature review.

Background and objectivePsychosocial costs, or quality of life costs, account for psychological distress, pain, suffering and other negative experiences associated with cancer. They contribute to the overall economic burden of cancer that patients experience. But this category of costs remains poorly understood. This hinders opportunities to make the best cancer control policy decisions. This study explored the psychosocial cost burden associated with cancer, how studies measure psychosocial costs and the impact of this burden.MethodsA systematic literature review of academic and grey literatu

Treatment and Prevention of Cancer-Associated Thrombosis in Frail Patients: Tailored Management.

Advanced age is one of the major determinants of frailty in patients with cancer-associated thrombosis. However, multiple other factors contribute to frailty in these patients. The identification of frailty in patients with cancer-associated thrombosis is critical as it influences the complexity of the anticoagulant treatment in this population at high risk of venous thromboembolism and bleeding. Factors that contribute to frailty in patients with cancer-associated thrombosis include age, type of cancer, comorbidities such as chronic kidney disease, poly-pharmacotherapy, treatment compliance,

Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative.

BACKGROUND: Gaucher disease (GD) presents with a range of signs and symptoms. Physicians can fail to recognise the early stages of GD owing to a lack of disease awareness, which can lead to significant diagnostic delays and sometimes irreversible but avoidable morbidities. AIM: The Gaucher Earlier Diagnosis Consensus (GED-C) initiative aimed to identify signs and co-variables considered most indicative of early type 1 and type 3 GD, to help non-specialists identify 'at-risk' patients who may benefit from diagnostic testing. METHODS: An anonymous, three-round Delphi consensus process was depl

Совпадение в полном тексте источника
… Patients may visit up to eight (mean: 3.0) different specialists, including internists, paediatricians, haematologists, medical oncologists, gastroenterologists, geneticists, neurologists, obstetricians/gynaecologists, orthopaedists and rheumatologists. 11 Figure 1 Type 1 Gaucher disease case study. … Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists‐oncologists and an opportunity for early diagnosis and intervention. Am J Hematol 2007; 82: 697–701. 12. Andrade‐Campos M, Alfonso P, Irun P, Armstrong J, Calvo C, Dalmau J et al. …

Local control and vertebral compression fractures following stereotactic body radiotherapy for spine metastases.

PURPOSE: We aimed to retrospectively assess the incidence of vertebral compression fractures (VCF), examine clinicopathologic factors potentially associated with VCF, and evaluate treatment response in patients who received stereotactic body radiotherapy (SBRT) for spine metastases (spMets). METHODS AND MATERIALS: We identified 78 patients with 125 spMets at baseline and subsequent assessments. Patients received SBRT doses of 16 or 18 Gy. Patients with pre-existing VCF and co-existing local progression were excluded. Spine instability neoplastic score (SINS) was used for spMets categorization

Совпадение в полном тексте источника
… In our center, PET/CT is utilized frequently by both radiation and medical oncologists to monitor disease status. MRI was also performed for refractory pain and neurological symptoms to exclude VCF or if the baseline tool before SBRT was MRI. … Oncologist. 2013;18(6):744–751. doi: 10.1634/theoncologist.2012-0293. 6. Foote M., Letourneau D., Hyde D., Massicotte E., Rampersaud R., Fehlings M., Fisher C., Lewis S., Macchia N.L., Yu E. Technique for stereotactic body radiotherapy for spinal metastases. J. Clin. …

Perspectives on the DNR decision process: A survey of nurses and physicians in hematology and oncology.

IntroductionIn cancer care, do-not-resuscitate (DNR) decisions are made frequently; i.e., decisions not to start the heart in the event of a cardiac arrest. A DNR decision can be a complex process involving nurses and physicians with a wide variety of experiences and perspectives. Previous studies have shown different perceptions of the DNR decision process among nurses and physicians, e.g. concerning patient involvement and information. DNR decisions have also been reported to be unclear and documentation inconsistent.ObjectiveThe aim was to investigate how important and how likely to happen

Совпадение в полном тексте источника
… What keeps oncologists from addressing palliative care early on with incurable cancer patients? An active stance seems key . Oncologist . 2015 1 10.1634/theoncologist.2014-0031 25361623 10.1634/theoncologist.2014-0031 PMC4294613 22 Mahon MM , McAuley WJ . … Factors Influencing Head and Neck Surgical Oncologists' Transition from Curative to Palliative Treatment Goals . Otolaryngol Head Neck Surg . 2016 9 13 10.1177/0194599816667712 27625024 10.1177/0194599816667712 24 Yuen JK , Reid MC , Fetters MD . …

Biosimilar Retacrit® (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) - non-interventional study.

BackgroundSymptomatic anemia is a frequent and severe complication of chemotherapy that is commonly treated with erythropoiesis-stimulating agents. The primary objective of this study was to assess the change in hemoglobin levels in patients with chemotherapy-induced anemia (CIA) following treatment with biosimilar Retacrit® (epoetin zeta). Secondary objectives included changes in hematologic parameters and tolerability.MethodsThis was a non-interventional, multicenter, long-term observational study that is part of an ongoing surveillance program for epoetin zeta. Adult patients (N=291) with s

Совпадение в полном тексте источника
… Secondary objectives were to evaluate the profiles of treated patients, evaluate the treatment plans for each prescriber, observe changes in blood values in each subgroup, evaluate the correlation between the therapy plans of prescribing oncologists and patient characteristics, and assess the tolerability … Oncologist. 2008;13(Suppl 3):33–36. doi: 10.1634/theoncologist.13-S3-33. 21. Theobald K, Capan M, Herbold M, Schinzel S, Hundt F. Quality assurance in non-interventional studies. Ger Med Sci. 2009;7:29. doi: 10.3205/000088. 22. Bokemeyer C, Aapro MS, Courdi A, et al. …

Correlates of exercise motivation and behavior in a population-based sample of endometrial cancer survivors: an application of the Theory of Planned Behavior.

BackgroundDespite evidence of the benefits of exercise in cancer survivors, exercise participation rates tend to decline after treatments. Few studies have examined the determinants of exercise in less common cancer sites. In this study, we examined medical, demographic, and social cognitive correlates of exercise in endometrial cancer survivors using the Theory of Planned Behavior (TPB).MethodsA mailed survey was completed by 354 endometrial cancer survivors (1 to 10 years postdiagnosis) residing in Alberta, Canada. The study was cross-sectional. Exercise behavior was assessed using the Godin

Abstracts From JADPRO Live 2019: Washington State Convention Center • Seattle • October 24-27.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… Nurse practitioners and oncologists were most commonly reported as the source of bone health information, with similar findings for all subgroups. … Commonly, APP SC clinics transition patients from their primary oncologist to the APP clinic after approximately two years post-RT. …

Physical activity programming and counseling preferences among cancer survivors: a systematic review.

BackgroundPhysical activity (PA) participation and adherence among cancer survivors is low, despite research indicating numerous physical, psychological and emotional health benefits of exercise. Tailoring exercise programs specific to the PA preferences in cancer survivors has merit for increasing PA participation and adherence to accrue these benefits. This systematic review identifies and differentiates PA programming and counseling preferences of adult cancer survivors across various cancer survivor groups.MethodsPubMed, SPORTDiscus, Scopus, PsycINFO, EMBASE, Web of Science and CINAHL were

Совпадение в полном тексте источника
… PA specialist, exercise physiologist) from a community or a cancer center, nurses, oncologists or other cancer survivors. … The second most common preference for PA counseling or information delivery was from a health practitioner (i.e., specialist nurse, physician, or oncologist) [ 50 , 53 , 78 ]. …

The impact of early integrated palliative care on symptom burden and quality of life in patients with advanced breast cancer.

UNLABELLED: Patients with advanced breast cancer endure a high symptom burden and impaired quality of life. This study evaluated the impact of Early Integrated Palliative Care (EIPC) on these outcomes. METHODS: A retrospective cohort study analyzed patients with advanced breast cancer treated between November 2018 and December 2021. Patients were categorized into an EIPC group or a usual care group based on the care model received. Symptom burden (SDS) and sleep quality (PSQI) were assessed at baseline, 6, 12, 18, and 24 weeks. Quality of life (FACT-B), hope (HHI), and anxiety/depression (HAD